SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 373 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,167,362 | -3.0% | 9,630 | -8.4% | 0.00% | 0.0% |
| Q2 2023 | $1,203,964 | +207.3% | 10,513 | +269.8% | 0.00% | +100.0% |
| Q1 2023 | $391,849 | +43.0% | 2,843 | +14.9% | 0.00% | – |
| Q3 2022 | $274,000 | +21.8% | 2,475 | -17.4% | 0.00% | – |
| Q2 2022 | $225,000 | -3.8% | 2,996 | 0.0% | 0.00% | – |
| Q1 2022 | $234,000 | -37.6% | 2,996 | -28.0% | 0.00% | – |
| Q4 2021 | $375,000 | -6.9% | 4,161 | -4.5% | 0.00% | -100.0% |
| Q3 2021 | $403,000 | +57.4% | 4,357 | +32.4% | 0.00% | – |
| Q2 2021 | $256,000 | -2.7% | 3,291 | -6.5% | 0.00% | – |
| Q1 2021 | $263,000 | -66.9% | 3,519 | -24.4% | 0.00% | -100.0% |
| Q4 2020 | $794,000 | +13.9% | 4,657 | -6.3% | 0.00% | 0.0% |
| Q3 2020 | $697,000 | -18.7% | 4,970 | -7.1% | 0.00% | -50.0% |
| Q2 2020 | $857,000 | +61.1% | 5,348 | -1.4% | 0.00% | +100.0% |
| Q1 2020 | $532,000 | -19.6% | 5,426 | +6.1% | 0.00% | 0.0% |
| Q4 2019 | $662,000 | -9.3% | 5,114 | +6.8% | 0.00% | -50.0% |
| Q2 2019 | $730,000 | -83.0% | 4,787 | -86.7% | 0.00% | -83.3% |
| Q1 2019 | $4,297,000 | +13.9% | 36,022 | +4.3% | 0.01% | 0.0% |
| Q4 2018 | $3,772,000 | -27.3% | 34,526 | +7.4% | 0.01% | -20.0% |
| Q3 2018 | $5,191,000 | +20.9% | 32,142 | -1.1% | 0.02% | +15.4% |
| Q2 2018 | $4,293,000 | +73.2% | 32,489 | -2.8% | 0.01% | +62.5% |
| Q1 2018 | $2,479,000 | +35.4% | 33,436 | +1.7% | 0.01% | +33.3% |
| Q4 2017 | $1,831,000 | +52.3% | 32,891 | +24.2% | 0.01% | +50.0% |
| Q3 2017 | $1,202,000 | +33.4% | 26,491 | -1.0% | 0.00% | +33.3% |
| Q2 2017 | $901,000 | +127.0% | 26,766 | +100.3% | 0.00% | +50.0% |
| Q1 2017 | $397,000 | +29.3% | 13,366 | +19.3% | 0.00% | +100.0% |
| Q4 2016 | $307,000 | -71.3% | 11,201 | -35.6% | 0.00% | -80.0% |
| Q3 2016 | $1,068,000 | +142.2% | 17,401 | -24.6% | 0.01% | +150.0% |
| Q2 2016 | $441,000 | +3.3% | 23,076 | +5.4% | 0.00% | 0.0% |
| Q1 2016 | $427,000 | -24.2% | 21,898 | +50.0% | 0.00% | -33.3% |
| Q4 2015 | $563,000 | +20.0% | 14,598 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $469,000 | -47.5% | 14,598 | -50.3% | 0.00% | +50.0% |
| Q2 2015 | $894,000 | +360.8% | 29,396 | +101.4% | 0.00% | +100.0% |
| Q1 2015 | $194,000 | -10.2% | 14,598 | -2.3% | 0.00% | 0.0% |
| Q4 2014 | $216,000 | -28.5% | 14,948 | +4.5% | 0.00% | -66.7% |
| Q3 2014 | $302,000 | -29.1% | 14,298 | 0.0% | 0.00% | -25.0% |
| Q2 2014 | $426,000 | +18.7% | 14,298 | -4.3% | 0.00% | +33.3% |
| Q1 2014 | $359,000 | – | 14,948 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 290,000 | $44,066,000 | 9.14% |
| Avoro Capital Advisors LLC | 1,400,000 | $212,730,000 | 7.35% |
| NEXTHERA CAPITAL LP | 50,317 | $7,646,000 | 6.37% |
| Eventide Asset Management | 1,123,000 | $170,640,000 | 5.19% |
| RTW INVESTMENTS, LP | 604,236 | $91,814,000 | 4.90% |
| Casdin Capital, LLC | 335,000 | $50,903,250,000 | 4.76% |
| Copernicus Capital Management, LLC | 30,000 | $4,559,000 | 4.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 548,500 | $83,345,000 | 3.76% |
| Camber Capital Management LP | 500,000 | $75,975,000 | 3.54% |
| Dynamic Capital Management Ltd | 4,677 | $711,000 | 3.54% |